Translational Development Acquisition Corp.
- Last sale
- Nov 10, 2026
- Market cap
- $209.50M
- 19.31M shares
- Filings
- 84
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
—
—
——
—
—Q3 2026−93.2% FY25 yoy
- $209.50M
- 32.9×
- —
- —
- —
- —
FY2025 figures · derived
Price
Nov 10, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
General And Administrative
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $944,538 | reported | |
| FY 2024 | 2024-12-31 | $196,358 | reported |
Blank check companies
Translational Development Acquisition Corp. is the 170th largest of the 307 covered companies the SEC files under this code, by market cap. SIC 6770
CompanyRevenueGrowthNet marginMarket cap
GSHRGesher Acquisition Corp. II———$216.3MHAVAHarvard Ave Acquisition Corp———$212.1MIDACIron Dome Acquisition I Corp.———$212.0MEGHAEGH Acquisition Corp.———$210.9MPALOPaloma Acquisition Corp I———$210.5M
TDACTranslational Development Acquisition Corp. (this company)———$209.5M
WLIIWillow Lane Acquisition Corp. II———$206.5MTHEOBOA Acquisition Corp. II———$205.7MKTWOK2 Capital Acquisition Corp———$202.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Translational Development Acquisition Corp. · CIK 1926599 · Engraved from SEC EDGAR